Wellington Management Group LLP Exact Sciences Corp Transaction History

Wellington Management Group LLP

  • $545 Billion
  • Q3 2025

A detailed history of Wellington Management Group LLP transactions in Exact Sciences Corp stock. As of the latest transaction made, Wellington Management Group LLP holds 5,325,981 shares of EXAS stock, worth $357 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
5,325,981
Previous 12,003,790 55.63%
Holding current value
$357 Million
Previous $638 Million 54.32%
% of portfolio
0.05%
Previous 0.12%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025
SELL
$40.91 - $56.0 $273 Million - $374 Million
-6,677,809 Reduced 55.63%
5,325,981 $291 Million
Q2 2025

Aug 14, 2025
SELL
$40.31 - $58.08 $20.1 Million - $28.9 Million
-497,526 Reduced 3.98%
12,003,790 $638 Million
Q1 2025

May 13, 2025
BUY
$43.04 - $58.51 $538 Million - $731 Million
12,501,316 New
12,501,316 $541 Million
Q4 2024

Feb 12, 2025
SELL
$49.33 - $71.97 $112 Million - $164 Million
-2,273,697 Reduced 15.86%
12,058,540 $678 Million
Q3 2024

Nov 14, 2024
SELL
$42.43 - $70.83 $19.4 Million - $32.3 Million
-456,174 Reduced 3.08%
14,332,237 $976 Million
Q2 2024

Aug 13, 2024
BUY
$41.33 - $74.26 $170 Million - $305 Million
4,108,572 Added 38.47%
14,788,411 $625 Million
Q1 2024

May 15, 2024
BUY
$56.27 - $73.77 $601 Million - $788 Million
10,679,839 New
10,679,839 $738 Million
Q4 2023

Feb 12, 2024
BUY
$59.06 - $75.72 $607 Million - $778 Million
10,280,814 New
10,280,814 $761 Million
Q3 2023

Nov 14, 2023
BUY
$65.94 - $99.04 $1.15 Million - $1.73 Million
17,511 Added 0.16%
10,820,873 $738 Million
Q2 2023

Aug 14, 2023
SELL
$62.68 - $95.05 $2.14 Million - $3.24 Million
-34,093 Reduced 0.31%
10,803,362 $1.01 Billion
Q1 2023

May 12, 2023
BUY
$47.19 - $70.77 $27.6 Million - $41.4 Million
585,517 Added 5.71%
10,837,455 $735 Million
Q4 2022

Feb 13, 2023
SELL
$30.35 - $53.15 $29.6 Million - $51.9 Million
-975,696 Reduced 8.69%
10,251,938 $508 Million
Q3 2022

Nov 14, 2022
BUY
$31.97 - $49.37 $36.6 Million - $56.5 Million
1,143,892 Added 11.34%
11,227,634 $365 Million
Q2 2022

Aug 15, 2022
SELL
$35.61 - $76.23 $87.7 Million - $188 Million
-2,463,167 Reduced 19.63%
10,083,742 $397 Million
Q1 2022

May 16, 2022
BUY
$57.56 - $82.54 $89.4 Million - $128 Million
1,553,934 Added 14.14%
12,546,909 $877 Million
Q4 2021

Feb 11, 2022
BUY
$72.5 - $100.68 $304 Million - $422 Million
4,193,111 Added 61.66%
10,992,975 $856 Million
Q3 2021

Nov 15, 2021
BUY
$90.24 - $124.05 $280 Million - $385 Million
3,100,449 Added 83.81%
6,799,864 $649 Million
Q2 2021

Aug 16, 2021
BUY
$93.66 - $139.27 $6.82 Million - $10.1 Million
72,764 Added 2.01%
3,699,415 $460 Million
Q1 2021

May 17, 2021
SELL
$116.57 - $155.01 $250 Million - $333 Million
-2,146,032 Reduced 37.18%
3,626,651 $478 Million
Q4 2020

Feb 12, 2021
BUY
$99.61 - $142.12 $173 Million - $247 Million
1,739,944 Added 43.15%
5,772,683 $765 Million
Q3 2020

Nov 16, 2020
BUY
$72.92 - $102.01 $48.9 Million - $68.3 Million
669,924 Added 19.92%
4,032,739 $411 Million
Q2 2020

Aug 14, 2020
SELL
$55.75 - $92.75 $7.24 Million - $12 Million
-129,896 Reduced 3.72%
3,362,815 $292 Million
Q1 2020

May 14, 2020
BUY
$37.9 - $104.44 $58.3 Million - $161 Million
1,538,521 Added 78.73%
3,492,711 $203 Million
Q4 2019

Feb 11, 2020
BUY
$77.66 - $99.74 $152 Million - $195 Million
1,954,190 New
1,954,190 $181 Million

Others Institutions Holding EXAS

# of Institutions
667
Shares Held
159M
Call Options Held
1.37M
Put Options Held
1.69M
View Full List

About EXACT SCIENCES CORP

EXAS Quotes by TradingView
  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $11.9B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Wellington Management Group LLP Portfolio

Follow Wellington Management Group LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

News

Stay updated on Wellington Management Group LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email